Cubicin
Links shared publicly online about this topic
Eosinophilic Pneumonia Linked With Cubicin Use
medicalnewstoday.com — “FDA releases drug safety communication warning of potential to acquire this serious condition when receiving intravenous antibacterial daptomycin.Patients and health professionals have” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 12:05 pm By:
MNT Infect Diseases Health News
Eosinophilic Pneumonia Linked With Cubicin Use http://mnt.to/3GSp #viruses #bacteria
FDA warns of eosinophilic pneumonia risk with Cubicin - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 29, 2010 at 4:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA warns of eosinophilic pneumonia risk with Cubicin http://goo.gl/fb/EeN7V
FDA warns of eosinophilic pneumonia risk with Cubicin - MPR
empr.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: FDA warns of eosinophilic pneumonia risk with Cubicin: The FDA has notified healthcare professionals and... http://bit.ly/9UDpdZ
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of Cubicin
drugs.com — “Cubicin (daptomycin) is used to treat complicated skin and skin structure infections and bacteremia. Includes Cubicin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 7, 2010 at 11:06 pm By:
Drugs and Devices OW OW Health
Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of Cubicin: LEXINGTON, Mass.--(BUSI... http://bit.ly/haWuay #drug
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
drugs.com — “FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 2:34 am By:
FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
fda.gov — “Cases of serious, potentially fatal pneumonia associated with the IV antibacterial drug Cubicin.” View full resource at fda.gov
Most Recently Shared on July 30, 2010 at 11:40 am By:
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: Cases of serious, potentially ... http://bit.ly/bTeVBr
The FDA warns about pneumonia caused by antibiotic Cubicin - latimes.com
latimes.com — “The Food and Drug Administration Thursday warned physicians and patients that the intravenous antibiotic Cubicin can cause life-threatening eosinophilic pneumonia, which is marked by the accumulation of a type of white blood cells called eosinophils in the lungs. Symptoms include fever, cough, shortness of breath and difficulty breathing.” View full resource at latimes.com
Most Recently Shared on July 31, 2010 at 6:20 pm By:
Health Literacy Medical School
#FDA warns about #pneumonia caused by #antibiotic #Cubicin http://ow.ly/2iFso
Cubist Pharmaceuticals Receives FDA Approval For 2-Minute IV Injection Of CUBICIN
medicalnewstoday.com — “Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced that its currently-marketed antibiotic, CUBICIN® (daptomycin for injection), has been approved by the U.S. Food & Drug Administration (FDA” View full resource at medicalnewstoday.com
Most Recently Shared on December 6, 2010 at 3:06 pm By:
Cubist Pharmaceuticals Receives FDA Approval For 2-Minute IV Injection Of CUBICIN http://mnt.to/3NBh #mrsa
FDA Says Cubicin May Cause Deadly Form of Pneumonia
newsinferno.com — “FDA Says Cubicin May Cause Deadly Form of Pneumonia” View full resource at newsinferno.com
Most Recently Shared on July 29, 2010 at 9:17 pm By:
FDA Says Cubicin May Cause Deadly Form of Pneumonia: The antibiotic Cubicin (daptomycin) has been associated with ... http://bit.ly/bIzBA8
FDA approves 2-Minute IV injection of Cubicin - ONA
oncologynurseadvisor.com — “Cubist Pharmaceuticals announced that the FDA has approved a new administration method for Cubicin (daptomycin for injection) to include a once-a-day 2-minute intravenous (IV) injection.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 2, 2010 at 3:31 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA approves 2-Minute IV injection of Cubicin http://goo.gl/fb/0XVFr
FDA approves 2-Minute IV injection of Cubicin - MPR
empr.com — “Cubist Pharmaceuticals announced that the FDA has approved a new administration method for Cubicin (daptomycin for injection) to include a once-a-day 2-minute intravenous (IV) injection.” View full resource at empr.com
Most Recently Shared on December 2, 2010 at 3:29 pm By:
MPR News: FDA approves 2-Minute IV injection of Cubicin: Cubist Pharmaceuticals announced that the FDA has appro... http://bit.ly/gmd243
Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint
news-medical.net — “Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.” View full resource at news-medical.net
Most Recently Shared on July 19, 2010 at 1:01 pm By:
Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint: Cubist Pharmaceuticals, Inc., a lead... http://bit.ly/9xNdNV
Cubist Says FDA Approves Fast-Injection Cubicin - Drugs.com MedNews
drugs.com — “From Associated Press (December 1, 2010) Cubist Pharmaceuticals Inc. said Wednesday that regulators gave a new approval to its antibiotic Cubicin, allowing Cubi” View full resource at drugs.com
Most Recently Shared on December 2, 2010 at 3:12 pm By:
Drugs and Devices OW OW Health
Cubist Says FDA Approves Fast-Injection Cubicin: From Associated Press (December 1, 2010) Â LEXINGTON, Mas... http://bit.ly/hJHToU #drug
FDA warns about pneumonia risk linked to antibiotic Cubicin - Related Stories - ANA SmartBrief
smartbrief.com — “The FDA said patients treated with Cubist Pharmaceuticals' injectable antibiotic Cubicin might deve” View full resource at smartbrief.com
Most Recently Shared on July 30, 2010 at 5:22 pm By:
Oklahoma Nurses Health Organization
FDA warns about pneumonia risk linked to antibiotic Cubicin http://sbne.ws/r/5ggy #fb
Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com
aboutlawsuits.com — “Federal drug safety regulators are warning doctors and patients that the intravenous antibiotic Cubicin may increase the risk of pneumonia. On Thursday,” View full resource at aboutlawsuits.com
Most Recently Shared on July 30, 2010 at 2:32 pm By:
Monica R.Gaidhane Doctor and Physician
Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com: http://bit.ly/dhpN2y via @addthis
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Infect Diseases
The latest infectious diseases / bacteria / viruses news published daily. Articles from research centers, universities and prestigious journals.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
